M

MeiraGTx Holdings plc
D

MGTX

8.71000
USD
-0.07
(-0.80%)
مغلق
حجم التداول
15,740
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
700,697,525
أصول ذات صلة الأخبار المقالات

العنوان: MeiraGTx Holdings plc

القطاع: Healthcare
الصناعة: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.